A statue of Amgen co-founder William K. Bowes Jr. stands watch over the Thousand Oaks campus. Story updated at 4 p.m. Aug. 26: Shares for the region’s biotech heavyweight popped 3 percent Aug. 26 after it announced plans to add a psoriasis drug to its portfolio. Amgen said it will spend $13.4 billion in cash…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
